tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksMost Visited WebsitesTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Smart Growth
New
Research Tools
Stock ScreenerETF Screener
Popular
Trending StocksDaily Analyst RatingsCompare StocksCompare ETFsPenny Stock ScreenerTechnical Analysis ScreenerDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsTop Online BrokersBecome an Affiliate
Follow Us
NewsTrendingPortfolio
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Notification Center
Top ETFs
Top Smart Score Stocks
Popular
Earnings
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Plans & Pricing
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
Most Visited Websites
TipRanks Momentum Index
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock Screener
ETF Screener
Popular
Trending Stocks
Daily Analyst Ratings
Compare Stocks
Compare ETFs
Penny Stock Screener
Technical Analysis Screener
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Class Actions
Class Actions
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
Follow Us

ACRX

Two option delistings on January 11th
The FlyTwo option delistings on January 11th
11M ago
ACRX
TRMR
AcelRx changing its name to Talphera
PremiumThe Fly
AcelRx changing its name to Talphera
11M ago
ACRX
AcelRx changing its name to Talphera
PremiumThe Fly
AcelRx changing its name to Talphera
11M ago
ACRX
AcelRx files $150M mixed securities shelf
PremiumThe Fly
AcelRx files $150M mixed securities shelf
1y ago
ACRX
Is ACRX a Buy, Before Earnings?
PremiumPre-Earnings
Is ACRX a Buy, Before Earnings?
1y ago
ACRX
AcelRx receives FDA approval for pivotal study of Niyad
PremiumThe FlyAcelRx receives FDA approval for pivotal study of Niyad
1y ago
ACRX
AcelRx initiated with a Buy at Alliance Global Partners
Premium
The Fly
AcelRx initiated with a Buy at Alliance Global Partners
1y ago
ACRX
AcelRx: FDA declined to issue EUA for Niyad at this time
Premium
The Fly
AcelRx: FDA declined to issue EUA for Niyad at this time
1y ago
ACRX
AcelRx price target lowered to $5 from $8 at H.C. Wainwright
PremiumThe Fly
AcelRx price target lowered to $5 from $8 at H.C. Wainwright
1y ago
ACRX
AcelRx upgraded to Buy from Neutral at H.C. Wainwright
PremiumThe Fly
AcelRx upgraded to Buy from Neutral at H.C. Wainwright
1y ago
ACRX
ACRX Upcoming Earnings Report: What to Expect?
PremiumPre-Earnings
ACRX Upcoming Earnings Report: What to Expect?
1y ago
ACRX
AcelRx files to sell 5.34M shares of common stock for holders
PremiumThe Fly
AcelRx files to sell 5.34M shares of common stock for holders
1y ago
ACRX
AcelRx sells 5.34M shares at $1.36 in private placement priced ATM
PremiumThe FlyAcelRx sells 5.34M shares at $1.36 in private placement priced ATM
1y ago
ACRX
ACRX Earnings Report this Week: Is It a Buy, Ahead of Earnings?
Premium
Pre-Earnings
ACRX Earnings Report this Week: Is It a Buy, Ahead of Earnings?
2y ago
ACRX
AcelRx reports Q4 EPS ($1.00) vs. ($1.24) last year
Premium
The Fly
AcelRx reports Q4 EPS ($1.00) vs. ($1.24) last year
2y ago
ACRX
Acelrx Pharmaceuticals (ACRX) Q4 Earnings Cheat Sheet
PremiumPre-Earnings
Acelrx Pharmaceuticals (ACRX) Q4 Earnings Cheat Sheet
2y ago
ACRX
AcelRx divests Dsuvia to Alora Pharmaceuticals
PremiumThe Fly
AcelRx divests Dsuvia to Alora Pharmaceuticals
2y ago
ACRX
AcelRx announces peer-reviewed publication related to use of sufentanil
PremiumThe Fly
AcelRx announces peer-reviewed publication related to use of sufentanil
2y ago
ACRX
AcelRx announces $7.5M registered direct offering
PremiumThe Fly
AcelRx announces $7.5M registered direct offering
2y ago
ACRX
AcelRx’s sufentanil tablets for post-operative pain featured in publication
PremiumThe FlyAcelRx’s sufentanil tablets for post-operative pain featured in publication
2y ago
ACRX
AcelRx reports Q3 EPS (94c), two estimates ($1.20)
Premium
The Fly
AcelRx reports Q3 EPS (94c), two estimates ($1.20)
2y ago
ACRX
Understanding AcelRx Pharma’s Risk Factors Post Q2
Premium
Market News
Understanding AcelRx Pharma’s Risk Factors Post Q2
3y ago
ACRX

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >